Literature DB >> 24781937

Comparison of in vivo efficacy of different ocular lubricants in dry eye animal models.

Xiaodong Zheng1, Tomoko Goto1, Yuichi Ohashi1.   

Abstract

PURPOSE: To compare the efficacy of three types of ocular lubricants in protecting corneal epithelial cells in dry eye animal models.
METHODS: Ocular lubricants containing 0.1% or 0.3% sodium hyaluronate (SH), carboxymethylcellulose (CMC), or hydroxypropyl methylcellulose (HPMC) were tested. First, ocular lubricant containing 0.002% fluorescein was dropped onto the rabbit corneas. The fluorescein intensity as an index of retention was measured. Second, a rabbit dry eye model was made by holding the eye open with a speculum, and 50 μL of each ocular lubricant was dropped onto the cornea. After 3 hours, the corneas were stained with 1% methylene blue (MB), and the absorbance of MB was measured. Third, a rat dry eye model was treated with the ocular lubricants for 4 weeks, and the corneal fluorescein staining was scored. Eyes treated with physiological saline were used as controls. Finally, immunohistochemistry was used to analyze occludin, an epithelial barrier protein, in cultured human corneal epithelial cells pretreated with ocular lubricants and desiccated for 20 or 60 minutes.
RESULTS: Our results showed that 0.3% SH had a significantly longer retention time than the other lubricants (all P < 0.01). The absorbance of MB was significantly lower in the 0.3% SH group. The corneas of rats exposed to 0.3% SH had significantly lower fluorescein staining scores. A significantly higher number of occludin-positive cells were found after exposure to 0.3% SH than other lubricants.
CONCLUSIONS: Ocular lubricant containing 0.3% SH would be preferable to treat patients with dry eye syndrome. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.

Entities:  

Keywords:  animal model; cornea; dry eye syndrome; ocular lubricant

Mesh:

Substances:

Year:  2014        PMID: 24781937     DOI: 10.1167/iovs.13-13730

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  11 in total

1.  Functionalized Hyaluronic Acid for "In Situ" Matrix Metalloproteinase Inhibition: A Bioactive Material to Treat the Dry Eye Sydrome.

Authors:  Susi Burgalassi; Marco Fragai; Oscar Francesconi; Linda Cerofolini; Daniela Monti; Gemma Leone; Stefania Lamponi; Giuseppe Greco; Agnese Magnani; Cristina Nativi
Journal:  ACS Macro Lett       Date:  2022-09-14       Impact factor: 7.015

2.  Antimicrobial Peptide P60.4Ac-Containing Creams and Gel for Eradication of Methicillin-Resistant Staphylococcus aureus from Cultured Skin and Airway Epithelial Surfaces.

Authors:  Elisabeth M Haisma; Anikó Göblyös; Bep Ravensbergen; Alwin E Adriaans; Robert A Cordfunke; Jasmijn Schrumpf; Ronald W A L Limpens; Kirsten J M Schimmel; Jan den Hartigh; Pieter S Hiemstra; Jan Wouter Drijfhout; Abdoelwaheb El Ghalbzouri; Peter H Nibbering
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

3.  Effects of Aqueous-Supplementing Artificial Tears in Wearers of Biweekly Replacement Contact Lenses vs Wearers of Daily Disposable Contact Lenses.

Authors:  Silvia Tavazzi; Riccardo Origgi; Martina Anselmi; Andrea Corvino; Sara Colciago; Matteo Fagnola; Silvia Bracco; Fabrizio Zeri
Journal:  Clin Optom (Auckl)       Date:  2020-06-25

4.  Efficacy and safety of two new formulations of artificial tears in subjects with dry eye disease: a 3-month, multicenter, active-controlled, randomized trial.

Authors:  Peter A Simmons; Haixia Liu; Cindy Carlisle-Wilcox; Joseph G Vehige
Journal:  Clin Ophthalmol       Date:  2015-04-15

Review 5.  Dry Eye Management: Targeting the Ocular Surface Microenvironment.

Authors:  Xiaobo Zhang; Vimalin Jeyalatha M; Yangluowa Qu; Xin He; Shangkun Ou; Jinghua Bu; Changkai Jia; Junqi Wang; Han Wu; Zuguo Liu; Wei Li
Journal:  Int J Mol Sci       Date:  2017-06-29       Impact factor: 5.923

6.  Comparison of the Efficacy of Carboxymethylcellulose 0.5%, Hydroxypropyl-guar Containing Polyethylene Glycol 400/Propylene Glycol, and Hydroxypropyl Methyl Cellulose 0.3% Tear Substitutes in Improving Ocular Surface Disease Index in Cases of Dry Eye.

Authors:  Prafulla K Maharana; Sapna Raghuwanshi; Ashish K Chauhan; Vaishali G Rai; Rajesh Pattebahadur
Journal:  Middle East Afr J Ophthalmol       Date:  2017 Oct-Dec

7.  A Randomized Multicenter Study Comparing 0.1%, 0.15%, and 0.3% Sodium Hyaluronate with 0.05% Cyclosporine in the Treatment of Dry Eye.

Authors:  Yuli Park; Jong Suk Song; Chul Young Choi; Kyung Chul Yoon; Hyung Keun Lee; Hyun Seung Kim
Journal:  J Ocul Pharmacol Ther       Date:  2016-12-08       Impact factor: 2.671

8.  Achyranthis radix Extract-Loaded Eye Drop Formulation Development and Novel Evaluation Method for Dry Eye Treatment.

Authors:  Sung-Jin Kim; Bongkyun Park; Hyun Wook Huh; Young-Guk Na; Minki Kim; Mingu Han; Hyunmin Lee; Thi Mai Anh Pham; Hong-Ki Lee; Jae-Young Lee; Chan-Sik Kim; Jong-Suep Baek; Cheong-Weon Cho
Journal:  Pharmaceutics       Date:  2020-02-17       Impact factor: 6.321

9.  Hyaluronate Acid-Dependent Protection and Enhanced Corneal Wound Healing against Oxidative Damage in Corneal Epithelial Cells.

Authors:  Jing Zhong; Yuqing Deng; Bishan Tian; Bowen Wang; Yifang Sun; Haixiang Huang; Ling Chen; Shiqi Ling; Jin Yuan
Journal:  J Ophthalmol       Date:  2016-04-14       Impact factor: 1.909

10.  Gelatin Nanoparticles-HPMC Hybrid System for Effective Ocular Topical Administration of Antihypertensive Agents.

Authors:  Sergio Esteban-Pérez; Vanessa Andrés-Guerrero; José Javier López-Cano; Irene Molina-Martínez; Rocio Herrero-Vanrell; Irene Bravo-Osuna
Journal:  Pharmaceutics       Date:  2020-03-28       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.